Spruce Biosciences

About:

Spruce Biosciences is a biopharmaceutical company developing therapies for rare diseases that target the endocrine system.

Website: https://www.sprucebiosciences.com/

Top Investors: Sands Capital Ventures, Rock Springs Capital, Omega Funds, 5AM Ventures, Abingworth

Description:

Spruce Biosciences is a biopharmaceutical company developing therapies for rare diseases that target the endocrine system. The company is driven by a mission to develop meaningful therapies for patients with rare diseases affecting the hypothalamic-pituitary-adrenal. They are committed to transforming the quality of life for patients who have been underserved by scientific innovation.

Total Funding Amount:

$162M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

South San Francisco, California, United States

Founded Date:

2014-01-01

Contact Email:

info(AT)sprucebiosciences.com

Founders:

Alexis Howerton

Number of Employees:

11-50

Last Funding Date:

2023-02-09

IPO Status:

Public

Industries:

© 2025 bioDAO.ai